medigraphic.com
Colegio de Medicina Interna de México.

2015, Number 4

<< Back Next >>

Med Int Mex 2015; 31 (4)

Ebola. An emergent disease

Carrillo-Esper R, Díaz Ponce-Medrano JA, Peña-Pérez CA, Flores-Rivera OI, Barragán-Hernández IJ, Hernández-Trujillo E, Sáenz-Rodríguez SE, Nicasio-Delgado AQ

Language: Spanish
References: 51
Page: 454-464
PDF size: 870.56 Kb.


ABSTRACT

The Ebola virus causes an acute illness, which is often fatal. The average case fatality rate is around 50%. The current outbreak in west Africa is the largest and the most complex Ebola outbreak since the disperse was first discovered in 1976. On 2014, August 8, the WHO declared this outbreak a public health emergency of international concern. The aim of this paper is to review current concepts related to Ebola virus infection.


REFERENCES

  1. Organización Mundial de la Salud. Fiebre hemorrágica del Ébola en Sudán, 1976. Bull World Health Organ 1978;56:247-270.

  2. Organización Mundial de la Salud. Fiebre hemorrágica del Ébola, 1976. Informe de una convención internacional. Bull World Health Organ 1978;56:271-293.

  3. Cox NJ, McCormick JB, Johnson KM, Kiley MP. Evidence for two subtypes of Ebola virus based on oligonucleotide mapping of RNA. J Infect Dis 1983;147:272-275.

  4. Heymann DL, Weisfeld JS, Webb PA, Johnson KM, et al. Ebola hemorrhagic fever: Tandala, Zaire, 1977-1978. J Infect Dis 1980;142:372-376.

  5. Baron RC, McCormick JB, Zubeir OA. Ebola virus disease in southern Sudan: hospital dissemination and intrafamilial spread. Bull World Health Organ 1983;61:997-1003.

  6. Georges AJ, Leroy EM, Renaud AA, Benissan CT, et al. Ebola hemorrhagic fever outbreaks in Gabon, 1994-1997: epidemiologic and health control issues. J Infect Dis 1999;179:65-75.

  7. Khan AS, Tshioko FK, Heymann DL, Le Guenno B, et al. The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. J Infect Dis 1999;179:76-86.

  8. Organización Mundial de la Salud. Fiebre hemorrágica del Ébola-Sudáfrica. Registro epidemiologico semanal 1996;71:359.

  9. Okware SI, Omaswa FG, Zaramba S, Opio A, et al. An outbreak of Ebola in Uganda. Trop Med Int Health 2002;7:1068-1075.

  10. Organización Mundial de la Salud. Brote(s) de la fiebre hemorrágica del Ébola, Congo y Gabón, octubre de 2001-julio de 2002. Registro epidemiológico semanal 2003;78:223-225.

  11. Formenty P, Libama F, Epelboin A, Allangar Y, et al. Outbreak of Ebola hemorrhagic fever in the Republic of the Congo, 2003: a new strategy? Med Trop (Mars) 2003;63:291-295.

  12. Organización Mundial de la Salud. Fiebre hemorrágica del Ébola en la República del Congo. Registro epidemiológico semanal 6 de enero de 2004.

  13. Organización Mundial de la Salud. Brote de la fiebre hemorrágica del Ébola en Yambio, Sudán del sur. Abril-junio 2004. Registro epidemiológico semanal 2005;80:370-375.

  14. Organización Mundial de la Salud. Fiebre hemorrágica del virus del Ébola, República Democrática del Congo-Actualización. Registro epidemiológico semanal 2007;82:345-346.

  15. MacNeil A, Farnon EC, Morgan OW, Gould P, et al. Filovirus outbreak detection and surveillance: lessons from Bundibugyo. J Infect Dis 2011;204:761-767.

  16. Organización Mundial de la Salud. Fin del brote de la enfermedad del Ébola en la República Democrática del Congo. Alerta y respuesta global 17 de febrero de 2009.

  17. Shoemaker T, MacNeil A, Balinandi S, Campbell S, et al. Reemerging Sudan Ebola virus disease in Uganda, 2011. Enferg Infect Dis 2012;18:1480-1483.

  18. Albariño CG, Shoemaker T, Khristova ML, Wamala JF, et al. Genomic analysis of filoviruses associated with four viral hemorrhagic fever outbreaks in Uganda and the Democratic Republic of the Congo in 2012. Virology 2013;442:97-100.

  19. Ebola Response Roadmap Situation Report. (Reporte de situación de la OMA para el brote de Ébola de África del Oeste en 2014): diciembre de 2014.

  20. Ansari AA. Clinical features and pathobiology of Ebola virus infection. J Autoimmun 2014;55:2-9.

  21. Ortiz J. Guía de bolsillo para el manejo del virus Ébola. Instituto Guatemalteco de Seguridad Social 2014;1:11-20.

  22. Wong G, Kobinger GP, Qiu X. Characterization of host immune responses in Ebola virus infections. Expert Rev Clin Immunol 2014;10:781-790.

  23. Martinez O, Johnson JC, Honko A, Yen B, et al. Ebola virus exploits a monocyte differentiation program to promote its entry. J Virol 2013;87:3801-3814.

  24. Draft who list of personal protective equipment for infection and prevention control with focus on Ebola classified by donation priority; 20 de octubre de 2014.

  25. Maganga GD, Kapetshi J, Berthet N, Pharm D, et al. Ebola virus disease in the Democratic Republic of Congo. N Engl J Med 2014;371:1-9.

  26. Meeting summary of the WHO consultation on potential Ebola therapies and vaccines. Geneva, Switzerland, 2014.

  27. SSA. Aviso preventivo de viaje a los países africanos: Guinea, Liberia y Sierra Leona ante brotes de enfermedad por virus ébola;20 de octubre de 2014.

  28. Wolz A. Face to face with Ebola–an emergency care center in Sierra Leone. N Engl J Med 2014;371:1081-1083.

  29. World Health Organization. Laboratory guidance for the diagnosis of Ebola virus disease, interim recommendations. Disponible en:http://apps.who.int/iris/bitstream/10665/134009/1/WHO_EVD_GUIDANCE_LAB_14.1_eng.pdf

  30. Aylward B, Barboza P, Bawo L, Bertherat E, et al. Ebola virus disease in West Africa–the first 9 months of the epidemic and forward projections. N Engl J Med 2014;371: 1481-1495.

  31. Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters CJ. ELISA for the detection of antibodies to Ebola viruses. J Infect Dis 1999;179:192-198.

  32. Chertow DS, Kleine C, Edwards JK, Scaini R, et al. Ebola virus disease in West Africa–clinical manifestations and management. N Engl J Med 2014;371:2054-2057.

  33. Bah EI, Lamah MC, Fletcher T, Jacob ST, et al. Clinical presentation of patients with Ebola virus disease in Conakry, Guinea. N Engl J Med 2015;372:40-47.

  34. Fowler RA, Fletcher T, Fischer WA, Lamontagne F, et al. Caring for critically ill patients with ebola virus disease. Perspectives from West Africa. Am J Respir Crit Care Med 2014;190:733-737.

  35. Centers for Disease, Control and Prevention. Case definition for Ebola Virus Disease (EVD). Disponible en http://www.cdc.gov/vhf/ebola/hcp/case-definition.html.

  36. Towner JS, Rollin PE, Bausch DG, Sanchez A, et al. Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol 2004;78:4330-441.

  37. Gire SK, Goba A, Andersen KG, Sealfon RS, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014;345:1369-1372.

  38. Ansari AA. Clinical features and pathobiology of ebolavirus infection. Department of Pathology & Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA; sept 2014.

  39. Formenty P, Leroy EM, Epelboin A, Libama F, et al. Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo. Clin Infect Dis 2006;42:1521-1526.

  40. Chan M. Ebola virus disease in West Africa–no early end to the outbreak. N Engl J Med 2014;371:1183-1185.

  41. Heinz Feldmann. Ebola–a growing threat? N Engl J Med 2014;371:1375-1378.

  42. Lyon GM, Mehta AK, Varkey JB, Brantly K, et al. Virus disease in the United States clinical care of two patients with Ebola for the emory serious communicable diseases Unit. N Engl J Med 2014;371:1-7.

  43. Oestereich L, Lüdtke A, Wurr S, Rieger T, et al. Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model. Elsevier 2014;105:17-21.

  44. Stock I. Marburg and Ebola hemorrhagic fevers–pathogens, epidemiology and therapy. Med Monatsschr Pharm 2014;37:324-330.

  45. Zhang Y, Li D, Jin X, Huang Z. Fighting Ebola with ZMapp: spotlight on plant-made antibody. Sci China Life Sci 2014;57:987-988.

  46. Allegran B, Christophe J, Eremin S, Formety P, et al. Interim infection pevention and control guidance for care of patients with suspected or confirmed filovirus hemorrhagic fever in health-care settings, with focus on ebola. WHO, 2014.

  47. WHO Guidance for immunization programmes in the African region in the context of Ebola. WHO information. Note version October 2014.

  48. WHO. Infection, prevention and control (IPC) Guidance Summary, Ebola guidance package, 2014.

  49. WHO. Clinical management of patients with viral hemorrhagic fever, interim emergency guidance-generic draft for west African adaptation, march 2014.

  50. Kreuels B, Wichmann D, Emmerich P, et al. A case of severe Ebola virus infection complicated by gram-negative septicemia. N Engl J Med 2014;371:2394-2401.

  51. Bray M, Mahanty S. Ebola hemorrhagic fever and septic shock. J Infect Dis 2003;188:1613-1617.




2020     |     www.medigraphic.com